Hypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low‐Birth‐Weight Infants After Prolonged Parenteral Nutrition Exposure

2020 ◽  
Author(s):  
Yin‐Ling Tan ◽  
Po‐Nien Tsao ◽  
Hung‐Chieh Chou ◽  
Ting‐An Yen ◽  
Chien‐Yi Chen
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Parenteral Nutrition ◽  
Bone Disease ◽  
Metabolic Bone Disease ◽  
Extremely Low Birth Weight ◽  
Low Birth Weight Infants ◽  
Disease Marker ◽  
Metabolic Bone

Copper Deficiency Presenting as Metabolic Bone Disease in Extremely Low Birth Weight, Short-Gut Infants

PEDIATRICS ◽  
2012 ◽  
Vol 130 (3) ◽  
pp. e695-e698 ◽  
Author(s):  
M. L. Marquardt ◽  
S. L. Done ◽  
M. Sandrock ◽  
W. E. Berdon ◽  
K. W. Feldman
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Bone Disease ◽  
Copper Deficiency ◽  
Metabolic Bone Disease ◽  
Extremely Low Birth Weight ◽  
Metabolic Bone

scholarly journals A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants: A Randomized Clinical Trial

2018 ◽  
Vol 194 ◽  
pp. 87-93.e1 ◽  
Author(s):  
Andreas Repa ◽  
Christoph Binder ◽  
Margarita Thanhaeuser ◽  
Alexandra Kreissl ◽  
Eleonore Pablik ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Birth Weight ◽  
Low Birth Weight ◽  
Parenteral Nutrition ◽  
Randomized Clinical Trial ◽  
Lipid Emulsion ◽  
Extremely Low Birth Weight ◽  
Low Birth Weight Infants

A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance

1991 ◽  
Vol 118 (6) ◽  
pp. 921-927 ◽  
Author(s):  
James W. Collins ◽  
Mark Hoppe ◽  
Karen Brown ◽  
Deborah V. Edidin ◽  
James Padbury ◽  
...  
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Parenteral Nutrition ◽  
Glucose Intolerance ◽  
Insulin Infusion ◽  
Controlled Trial ◽  
Extremely Low Birth Weight ◽  
Low Birth Weight Infants

Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia

1989 ◽  
Vol 114 (2) ◽  
pp. 273-280 ◽  
Author(s):  
Nancy D. Binder ◽  
Paula K. Raschko ◽  
Gerda I. Benda ◽  
John W. Reynolds
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Parenteral Nutrition ◽  
Insulin Infusion ◽  
Extremely Low Birth Weight ◽  
Low Birth Weight Infants

scholarly journals Preventive use of Calcitriol versus cholecalciferol on biochemical markers of Metabolic Bone Disease (MBD) in very low birth weight infants: a pilot randomized clinical trial

2021 ◽  
Author(s):  
Mohammad bagher Hosseini ◽  
Nafiseh Hosseini ◽  
Taher Entezari-Maleki ◽  
Zakieh Salimi
Keyword(s):  
Birth Weight ◽  
Low Birth Weight ◽  
Preterm Infants ◽  
Biochemical Markers ◽  
Metabolic Bone Disease ◽  
Very Low Birth Weight ◽  
Low Birth Weight Infants ◽  
Hydroxyvitamin D ◽  
Metabolic Bone ◽  
25 Hydroxyvitamin D

About 55% of extremely-low-birth-weight (birth weight < 1000 g) and 23% of very-low-birth-weight infants (birth weight < 1500 g) suffer from metabolic bone disease (MBD). There are limited data on the use of calcitriol (1, 25-dihydroxycholecalciferol) to prevent or treat MBD in preterm infants. Therefore, this study aimed to compare the preventive effect of calcitriol and cholecalciferol on the biochemical markers of MBD in preterm infants. This study was a pilot randomized controlled trial conducted in the Alzahra teaching hospital of Tabriz University of Medical Sciences. we randomized 72 very-low-birth-weight infants in two groups of calcitriol 0.25 µg/day and cholecalciferol 400 IU/day. Biochemical markers, including serum 25-hydroxyvitamin D, Alkaline phosphatase (ALP), Phosphorus (P), calcium (Ca), Parathyroid hormone (PTH), and tubular reabsorption of phosphate (TRP) levels were checked at baseline, three, and five weeks after medication, consecutively. After three weeks of supplementation, infants in the cholecalciferol group had higher levels of serum 25-hydroxyvitamin D (P=0.001) and lower levels of urine phosphate (P=0.009); There were no significant differences in other biochemical markers. At the end of the fifth week, there was no significant difference between the two groups in terms of biochemical markers. Conclusion: The study indicated that the use of cholecalciferol caused a lower urinary loss of phosphate in very-low-birth-weight infants at a short time; however, these findings were not sustained during the study period.

Sign in / Sign up

Export Citation Format

Share Document